Last reviewed · How we verify
Blood and Urine sampling — Competitive Intelligence Brief
phase 2
Diagnostics
Biologic
Live · refreshed every 30 min
Target snapshot
Blood and Urine sampling (Blood and Urine sampling) — Haugaard, Steen Bendix, M.D., DMSc. This drug involves the collection of blood and urine samples for diagnostic purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood and Urine sampling TARGET | Blood and Urine sampling | Haugaard, Steen Bendix, M.D., DMSc | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood and Urine sampling CI watch — RSS
- Blood and Urine sampling CI watch — Atom
- Blood and Urine sampling CI watch — JSON
- Blood and Urine sampling alone — RSS
Cite this brief
Drug Landscape (2026). Blood and Urine sampling — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-and-urine-sampling. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab